This story also ran on NPR. This story can be republished for free (details).

Kenneth Frazier, CEO of pharma giant Merck, is set to face senators Tuesday who say drug costs are “sky-high” and “out of control.”

But Frazier doesn’t need new talking points. Sixty years ago, a different panel of senators grilled a different Merck boss about the same problem.

To a striking degree, the subjects likely to surface Tuesday — high

Read More At Article Source | Article Attribution